Malloy Peter J, Xu Rong, Cattani Andreina, Reyes m Loreto, Feldman David
Department of Medicine, Stanford University School of Medicine, California 94305-5103, USA.
J Bone Miner Res. 2004 Jun;19(6):1018-24. doi: 10.1359/jbmr.2004.19.6.1018.
Hereditary vitamin D--resistant rickets (HVDRR) is a genetic disorder caused by mutations in the vitamin D receptor (VDR). In this study, we examined the VDR in a young boy who exhibited the typical clinical features of HVDRR but without alopecia.
The patient's VDR was studied using cultured dermal fibroblasts, and the recreated mutant VDR was analyzed in transfected cells.
The patient's fibroblasts were resistant to 1,25-dihydroxyvitamin D [1,25(OH)2D3], exhibiting only a slight induction of 24-hydroxylase gene expression when treated with 1 microM 1,25(OH)2D3 x [3H]1,25(OH)2D3 binding was absent in cell extracts from the patient's fibroblasts. Sequence analysis of the VDR gene uncovered a unique 5-bp deletion/8-bp insertion in exon 4. The mutation in helix HI of the ligand-binding domain deletes two amino acids (H141 and T142) and inserts three amino acids (L141, W142, and A143). In transactivation assays, the recreated mutant VDR was 1000-fold less active than the wildtype (WT) VDR. In glutathione S-transferase (GST) pull-down assays, the mutant VDR bound GST-retinoid X receptor (RXR) weakly in the absence of 1,25(OH)2D3; however, the binding did not increase with increasing concentrations of ligand. The mutant VDR did not bind to GST-vitamin D receptor interacting protein (DRIP) 205 at concentrations up to 1 microM 1,25(OH)2D3. We also examined effects of the three individual mutations on VDR transactivation. Only the insertion of A143 into the WT VDR disrupted VDR transactivation to the same extent observed with the natural mutation.
We describe a novel insertion/substitution mutation in helix Hl of the VDR ligand-binding domain (LBD) that abolishes ligand binding and result in the syndrome of HVDRR. This is the first time an insertion/substitution has been found as the defect-causing HVDRR.
遗传性维生素D抵抗性佝偻病(HVDRR)是一种由维生素D受体(VDR)突变引起的遗传性疾病。在本研究中,我们对一名表现出HVDRR典型临床特征但无脱发的小男孩的VDR进行了检测。
使用培养的皮肤成纤维细胞研究患者的VDR,并在转染细胞中分析重建的突变型VDR。
患者的成纤维细胞对1,25 - 二羟基维生素D [1,25(OH)2D3]具有抗性,在用1 microM 1,25(OH)2D3处理时,24 - 羟化酶基因表达仅略有诱导。患者成纤维细胞的细胞提取物中不存在[3H]1,25(OH)2D3结合。VDR基因的序列分析发现外显子4中有一个独特的5碱基缺失/8碱基插入。配体结合域螺旋HI中的突变删除了两个氨基酸(H141和T142)并插入了三个氨基酸(L141、W142和A143)。在反式激活试验中,重建的突变型VDR的活性比野生型(WT)VDR低1000倍。在谷胱甘肽S - 转移酶(GST)下拉试验中,在没有1,25(OH)2D3的情况下,突变型VDR与GST - 视黄醇X受体(RXR)的结合较弱;然而,随着配体浓度的增加,结合并未增加。在高达1 microM 1,25(OH)2D3的浓度下,突变型VDR不与GST - 维生素D受体相互作用蛋白(DRIP)205结合。我们还研究了三个单独突变对VDR反式激活的影响。只有将A143插入WT VDR会破坏VDR反式激活,其程度与自然突变观察到的相同。
我们描述了VDR配体结合域(LBD)螺旋Hl中的一种新型插入/替代突变,该突变消除了配体结合并导致HVDRR综合征。这是首次发现插入/替代作为导致HVDRR的缺陷。